Trending Topics

10 hours ago

The Top AI Chemistry Platforms Transforming Small Molecule Oncology in 2026

11 hours ago

Longevity at the Cellular Level: What Science Really Says

12 hours ago

Turbulence: The Hidden Enemy In Sterile Manufacturing

15 hours ago

Quantifying the ROI: Do AI Chemistry Platforms Actually Reduce Pharma R&D Costs?

1 day ago

Can Regulators Trust AI-Generated Scientific Data?

1 day ago

Why Microbial Biofilms Remain One Of Healthcare’s Toughest Challenges?

10 hours ago

The Top AI Chemistry Platforms Transforming Small Molecule Oncology in 2026

11 hours ago

Longevity at the Cellular Level: What Science Really Says

12 hours ago

Turbulence: The Hidden Enemy In Sterile Manufacturing

15 hours ago

Quantifying the ROI: Do AI Chemistry Platforms Actually Reduce Pharma R&D Costs?

1 day ago

Can Regulators Trust AI-Generated Scientific Data?

1 day ago

Why Microbial Biofilms Remain One Of Healthcare’s Toughest Challenges?

Breaking News

  • 1 day ago

  • Vaibhavi M.

Hetero Appoints Sameer Garaye as Vice President of Pharmaceutical R&D
Breaking News

More News

Automated Cell Therapy Manufacturing Secures $1.1 Billion Across 34 Funding Rounds Led by Cellares and Ori Biotech

Automated Cell Therapy Manufacturing Secures $1.1 Billion Across 34 Fu...

Simantini Singh Deo

Alembic Pharma Gains USFDA Tentative Approval for Binimetinib Tablets as Sole First Applicant

Alembic Pharma Gains USFDA Tentative Approval for Binimetinib Tablets ...

Simantini Singh Deo

Zydus Acquires Assertio in Deal Targeting US Specialty Pharma Portfolio Expansion

Zydus Acquires Assertio in Deal Targeting US Specialty Pharma Portfoli...

Simantini Singh Deo

Sanofi Gains Japan Approval for Sarclisa Subcutaneous Formulation in Multiple Myeloma

Sanofi Gains Japan Approval for Sarclisa Subcutaneous Formulation in M...

Vaibhavi M.

Ad
Advertisement

Interviews & Opinions

Article

From ₹250 a Month to Building Encube Ethicals: Mehul Shah on Entrepreneurship, Culture, Quality, and...

Mehul Shah took 11 years to hit Rs 25 crore in turnover, then waited again before owning his own R&D. On the ₹250 stipend, building Volini, the PACO f...

FT - Mr. Mehul Shah

Read More

Article
From Microbiologist to Pharma Leader : Hemanth Panasa on FDA Audits, Contamination Control & Aseptic Failures

FT - Mr. Hemanth Panasa

Article
“If You Want to Be a King, First Behave Like One” Naresh Kumar Gaur on Leadership & Ownership

FT - Mr. Naresh Kumar Gaur

Article
From ‘Why Reject?’ to ‘How Release?’: Deepak Kasbi on the Cultural Shift in Pharma Quality

FT - Mr. Deepak Kasbi

Ad
Advertisement
Ad